Breaking News
July 23, 2018 - Hand-Holding, Stress Ball Don’t Cut Anxiety in Skin CA Removal
July 23, 2018 - Biomarker is discovered for a flesh-eating pathogen that can blind or kill healthy young people
July 23, 2018 - Global warming could lead to additional suicides, new research indicates
July 23, 2018 - Researchers investigate recessive genetic disorder that leads to childhood blindness
July 23, 2018 - Imaging study shows how junk DNA activates genes
July 23, 2018 - Study assesses increased growth of secondary imaging interpretations
July 23, 2018 - Researchers present evidence of phage cooperation when attacking CRISPR-containing bacteria
July 23, 2018 - Endari (L-Glutamine) Supplement May Ease the Pain of Sickle Cell Disease
July 23, 2018 - Hidden blood in feces may signal deadly conditions
July 23, 2018 - Yeast species used in biotechnology, food industries causes drug-resistant yeast infections
July 23, 2018 - Breath analyses may help detect pancreatic cancer earlier, study shows
July 23, 2018 - Study reports data on dementia prevalence in sexual minority older adults
July 23, 2018 - Children of mothers with type 1 diabetes at greater risk of being overweight
July 23, 2018 - Deep brain stimulation found to improve diabetes symptoms
July 23, 2018 - New project explores health effects of dangerous chemicals
July 23, 2018 - New breeding technologies could enhance shape, size, color, and health benefits of produce
July 23, 2018 - Pfizer announces FDA approval of biosimilar to Neupogen
July 23, 2018 - Key questions to consider for sustainable management of environmental risks in Europe
July 23, 2018 - Vaxart Announces Publication of the Phase 1 Results of its Oral Norovirus Tablet Vaccine in Journal of Clinical Investigation Insight
July 23, 2018 - Joslin researchers report excessive fetal growth despite well-controlled type 1 diabetes
July 23, 2018 - Many patients concerned about financial impact of cancer diagnosis and treatment
July 23, 2018 - Former inmates more likely to die of opioid overdose after prison release
July 23, 2018 - New study offers robust insights into under-treatment of women with heart attacks
July 23, 2018 - Doctors’ ‘gut feelings’ play key role in medical decision making, finds study
July 23, 2018 - Tooth enamel that regrows? Researcher says revolutionary gel could make it possible
July 23, 2018 - ECU researchers develop world’s first blood test that detects melanoma in its early stages
July 23, 2018 - Researchers explore future of houseplants as functional sirens of home health
July 23, 2018 - No Outcome Differences Based on Anesthesia Team Make-Up
July 23, 2018 - Getting to the heart of congenital cardiac defects
July 23, 2018 - Healthy behaviors are not effective in preventing gestational diabetes in obese women
July 23, 2018 - Top of Teachers’ To-Do List: Focus on the Positives
July 23, 2018 - LDL quality is a novel, modifiable cardiovascular risk marker
July 22, 2018 - Researchers identify enzyme as potential new drug target for blood disorders
July 22, 2018 - Research shows that neurons can encode more than one signal at a time
July 22, 2018 - Exposure to secondhand smoke increases the risk of stillbirth
July 22, 2018 - Skin conditions by the numbers
July 22, 2018 - Brain tumour chemotherapy now available to even more NHS patients
July 22, 2018 - Researchers find mugwort pollen as major source of airborne endotoxins
July 22, 2018 - Occupational safety and health at workplace
July 22, 2018 - Pfizer And Lilly Announce Positive Top-Line Results From Phase 3 Trial Of Tanezumab For The Treatment Of Osteoarthritis (OA) Pain
July 22, 2018 - Early supper associated with lower risk of breast and prostate cancer
July 22, 2018 - Survey results identify major inequalities in acute stroke treatment across Europe
July 22, 2018 - Researchers discover promising treatment for genetic form of autism spectrum disorder
July 22, 2018 - Prenatal Depression More Common in Young Moms Today
July 22, 2018 - What helps adults with autism get and keep a job?
July 22, 2018 - Pediatric NEXUS Head CT DI guides selective imaging decisions in blunt trauma patients
July 22, 2018 - Novel tool predicts genes that cause disease due to production of truncated proteins
July 22, 2018 - AHA: Vaping Tied to Blood Clots — in Mice
July 22, 2018 - Study finds therapy dogs effective in reducing symptoms of ADHD
July 22, 2018 - Scientists find reason why malarial parasites are faster than immune cells
July 22, 2018 - Researchers gain more insight into how FUS protein causes ALS and FTLD
July 22, 2018 - Frequency of joint replacements halved in rheumatoid arthritis patients between 1997-2010
July 22, 2018 - QUT researcher highlights growing impact of non-prescription antibiotics supply in pharmacies
July 22, 2018 - UK health communication researcher seeks solutions for disposing leftover medicine
July 22, 2018 - Pfizer Initiates Pivotal Phase 3 Program for Investigational Hemophilia B Gene Therapy Fidanacogene Elaparvovec
July 22, 2018 - Mutation discovered to protect against Alzheimer’s disease in mice
July 22, 2018 - Researchers reveal how patients in urban areas develop multiple, long-term conditions
July 22, 2018 - Replacing conventional cancer treatment with complementary therapy linked to increased risk of death
July 22, 2018 - Study uncovers molecular key for delaying progression of multiple sclerosis
July 22, 2018 - Availability of athletic trainer in high school reduces injury rates in girls’ sports, shows study
July 22, 2018 - FDA Approves Krintafel (tafenoquine) for the Radical Cure of Plasmodium vivax Malaria
July 22, 2018 - Novel nuclear medicine probe will help assess new drugs for neurodegenerative diseases
July 22, 2018 - Physical activity even during exposure to air pollution can reduce risk of heart attack
July 22, 2018 - Scientists discover protein regulator of myelin production
July 22, 2018 - Sleep disturbances associated with higher dementia risk
July 22, 2018 - Scientists move one step further in developing eye drops to treat age-related macular degeneration
July 22, 2018 - Five-Year Stroke Rates Lower After PCI Versus CABG
July 21, 2018 - Alopecia areata – Genetics Home Reference
July 21, 2018 - Study identifies overdose risk factors in youth with substance use disorders
July 21, 2018 - Drug in clinical trials for Parkinson’s disease offers hope for treating heart failure
July 21, 2018 - Coupling free malaria tests with diagnosis-dependent vouchers can improve rational use of ACTs
July 21, 2018 - Sweetness depends on molecular interactions between specific sugars and water in saliva
July 21, 2018 - Muscle fitness is strongly associated with improved rate of ageing in the brain
July 21, 2018 - Resetting E-Prescriptions for Opioids Helps Curb Use: Study
July 21, 2018 - Overuse of antibiotics not what the doctor ordered
July 21, 2018 - Bundled-payment system did not lower costs for serious medical conditions, shows study
July 21, 2018 - Therapy dogs found to be effective in reducing ADHD symptoms in children
July 21, 2018 - Could rotating multiple therapists better treat PTSD patients?
July 21, 2018 - Binge drinking impairs working memory in adolescent brain
July 21, 2018 - Dying at home could be beneficial for terminally ill cancer patients and their relatives
Antiviral drug selectively targets the most aggressive viruses, research says

Antiviral drug selectively targets the most aggressive viruses, research says

image_pdfDownload PDFimage_print

An antiviral drug that inhibits a virus’ replication machinery selectively targets the most aggressive viruses, according to new research that looked at the infection of individual cells by a virus and the consequence of antiviral intervention. This new insight into the dynamics of an infection and the mechanism of an antiviral drug could not be seen by the typical approach of studying populations of cells. Researchers at Penn State, Duke University, and the University of Texas at Austin have developed a high-throughput system to study large numbers of single, infected cells that facilitated the new insight. A paper describing the results of the research appears in the journal Cell Reports.

“Traditionally, viruses and antiviral drugs are studied by infecting a population of cells with a population of viruses,” said Craig Cameron, professor and holder of the Eberly Family Chair in Biochemistry and Molecular Biology at Penn State and an author of the paper. “Both the cells and viruses vary somewhat individually, so the results that we get are averages over the population. Averages are fine when interested only in the efficacy of a drug, but studies on the single-cell level can tell you if particular members of the population are more susceptible to the treatment and when during the virus life cycle the treatment acts.”

To study the dynamics of a viral infection on individual cells, the researchers used a modified version of the poliovirus that produces a green-fluorescent protein. As a virus replicates in a cell, more and more of the green-fluorescent protein is produced, which the researchers can monitor. In order to study enough individual cells to get reliable, statistically significant results, the researchers built a microfluidic device that allows them to monitor up to 6,400 cells simultaneously.

“We treated cells infected with poliovirus with 2′-C-methyladenosine, a viral polymerase inhibitor that stops the virus from replicating its genome — a necessary step for the virus to produce more viruses,” said Jamie J. Arnold, an associate research professor at Penn State and another author of the paper. “This drug helped pave the way for the development of sofosbuvir, an antiviral drug that is part of the cocktail of drugs that is used to cure hepatitis C. As expected from previous studies, the drug eliminated about 50% of the infections, but we were surprised to see that the drug was most effective against viruses that were growing the fastest, something we could have never seen if we weren’t looking at cells individually.”

The researchers also followed the time course and dynamics of viral infections in individual cells. They studied the time at which the virus began to replicate, the rate of replication, and the maximum level of virus growth. By studying cells individually, the researchers were able to show which of these factors could be affected by slight variation between the cells and which could be affected by variation in the viruses.

“Some aspects of the dynamics of an infection seem to be controlled more by variation that exists between individual cells but other aspects are due to genetic variation within the virus population,” said Cameron. “With our new tool, we can begin to identify the specific factors that vary between the cells or between the viruses that are responsible for the different outcomes. Understanding these mechanisms will allow us to be smarter in the way we design new antiviral drugs.”​

Source:

http://science.psu.edu/news-and-events/2017-news/Cameron11-2017

Tagged with:

About author

Related Articles